Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

7 Indian pharma players race to develop COVID-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already......

'Worse for heart attacks': British Indian doc flags issues with Covishield

Eminent British-Indian Cardiologist Dr Aseem Malhotra, who has been leading international calls for the suspension of mRNA COVID-19 vaccines, said on Tuesday that Oxford-AstraZeneca's jab,......

50 lakh Covishield doses meant for export to UK to be used in India

Fifty lakh doses of 'Covishield' vaccine earmarked by the Serum Institute for export to the United Kingdom have now been made available for the inoculation of 18-44 age group in 21 states/UTs in......

Mankind Pharma Targets Anti-Obesity Drug

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' Photograph: Kind courtesy Mankind Pharma/Facebook.com   Mankind Pharma,......

India hasn't accepted UK 'data exclusivity' demand in FTA

India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic......

AstraZeneca India to delist scrip

AstraZeneca Pharma India, the Indian subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, has decided to delist its scrip from the Bombay Stock Exchange, National Stock Exchange and Bangalore......

Budget 2024: Wishlist of the pharma industry

There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical......